ACM
ANAB icon

ADAR1 Capital Management’s AnaptysBio ANAB Stock Holding History

ADAR1 Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Hold
3,698
– – 0.01% 243
2026
Q1 		$205K Buy
+3,698
New +$199K 0.01% 258
2025
Q1 		– Sell
-27,301
Closed -$361K – 212
2024
Q4 		$361K Sell
27,301
-165,419
-86% -$4.01M 0.07% 128
2024
Q3 		$6.46M Buy
192,720
+36,921
+24% +$1.26M 1.05% 22
2024
Q2 		$3.9M Buy
155,799
+154,799
+15,480% +$3.6M 0.74% 25
2024
Q1 		$22.5K Buy
+1,000
New +$23.7K 0.01% 214

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

ADAR1 Capital Management's ANAB Position: Q2 2026 in Review

ADAR1 Capital Management held its AnaptysBio (ANAB) position steady in Q2 2026 at 3,698 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #243.

ADAR1 Capital Management first reported a position in ANAB in Q1 2024 and has held it in 6 quarters since. The position peaked at $6.46M in Q3 2024. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • ADAR1 Capital Management held 3,698 shares of AnaptysBio worth $250K as of Q2 2026.
  • ADAR1 Capital Management left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up 0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #243 holding.
  • ADAR1 Capital Management first reported a position in AnaptysBio in Q1 2024 and has held it in 6 quarters since.
  • ADAR1 Capital Management's AnaptysBio position peaked at $6.46M in Q3 2024.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.